Entecavir as a first-line treatment for HBV reactivation following polychemotherapy for lymphoma

被引:29
作者
Colson, Philippe [1 ,2 ]
Borentain, Patrick [3 ]
Coso, Diane [4 ]
Chabannon, Christian [4 ]
Tamalet, Catherine [1 ,2 ]
Gerolami, Rene [3 ]
机构
[1] CHU Timone, Virol Lab, Federat Hosp, Bacteriol Virol Clin, Marseille 05, France
[2] Univ Aix Marseille 2, Fac Med & Pharm, CNRS, URMITE,IRD,UMR 6236, Marseille 05, France
[3] CHU Concept, Serv Hepatogastroenterol, Marseille 05, France
[4] Inst J Paoli I Calmettes, Serv Oncohematol, F-13009 Marseille, France
关键词
hepatitis B virus; reactivation; lymphoma; chemotherapy; haematopoietic stem cell transplantation; entecavir;
D O I
10.1111/j.1365-2141.2008.07318.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:148 / 150
页数:4
相关论文
共 8 条
[1]   Entecavir therapy for up to 96 weeks in patients with HBeAg-Positive chronic hepatitis B [J].
Gish, Robert G. ;
Lok, Anna S. ;
Chang, Ting-Tsung ;
De Man, Robert A. ;
Gadano, Adrian ;
Sollano, Jose ;
Han, Kwang-Hyub ;
Chao, You-Chen ;
Lee, Shou-Dong ;
Harris, Melissa ;
Yang, Joanna ;
Colonno, Richard ;
Brett-Smith, Helena .
GASTROENTEROLOGY, 2007, 133 (05) :1437-1444
[2]   Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B [J].
Lai, CL ;
Shouval, D ;
Lok, AS ;
Chang, TT ;
Cheinquer, H ;
Goodman, Z ;
DeHertogh, D ;
Wilber, R ;
Zink, RC ;
Cross, A ;
Colonno, R ;
Fernandes, L .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (10) :1011-1020
[3]   Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies [J].
Lalazar, Gadi ;
Rund, Deborah ;
Shouval, Daniel .
BRITISH JOURNAL OF HAEMATOLOGY, 2007, 136 (05) :699-712
[4]   Fatal postlymphoma chemotherapy hepatitis B reactivation secondary to the emergence of a YMDD mutant strain with lamivudine resistance in a noncirrhotic patient [J].
Law, Joanna K. ;
Al Ali, Jaber ;
Harrigan, P. Richard ;
Sherlock, Christopher H. ;
Savage, Kerry J. ;
Yoshida, Eric M. .
AMERICAN JOURNAL OF HEMATOLOGY, 2006, 81 (12) :969-972
[5]   Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B [J].
Liaw, YF ;
Leung, NWY ;
Chang, TT ;
Guan, R ;
Tai, DI ;
Ng, KY ;
Chien, RN ;
Dent, J ;
Roman, L ;
Edmundson, S ;
Lai, CL .
GASTROENTEROLOGY, 2000, 119 (01) :172-180
[6]   Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support [J].
Milpied, N ;
Deconinck, E ;
Gaillard, F ;
Delwail, V ;
Foussard, C ;
Berthou, C ;
Gressin, R ;
Lucas, V ;
Colombat, P ;
Harousseau, JL .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (13) :1287-1295
[7]   Entecavir for treatment of lamivudine-refractory, HBeAg-positive chronic hepatitis B [J].
Sherman, Morris ;
Yurdaydin, Cihan ;
Sollano, Jose ;
Silva, Marcelo ;
Liaw, Yun-Fan ;
Cianciara, Janusz ;
Boron-Kaczmarska, Anna ;
Martin, Paul ;
Goodman, Zachary ;
Colonno, Richard ;
Cross, Anne ;
Denisky, Gail ;
Kreter, Bruce ;
Hindes, Robert .
GASTROENTEROLOGY, 2006, 130 (07) :2039-2049
[8]   Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy [J].
Yeo, W ;
Johnson, PJ .
HEPATOLOGY, 2006, 43 (02) :209-220